Hisashi Kawata

Title: Hisashi Kawata: Innovator in Pharmaceutical Formulations

Introduction

Hisashi Kawata is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of glaucoma and ocular hypertension. With a total of 10 patents to his name, Kawata's work has had a substantial impact on medical science.

Latest Patents

Kawata's latest patents include innovative pharmaceutical formulations that utilize pyridylaminoacetic acid compounds. One notable patent provides a pharmaceutical preparation for the treatment or prevention of glaucoma or ocular hypertension. This preparation comprises 0.0003 to 0.01% (w/v) of isopropyl (6-{[4-(pyrazol-1-yl)benzyl] (pyridin-3-ylsulfonyl)aminomethyl}pyridin-2-ylamino)acetate, or a salt thereof. Another significant patent focuses on a pharmaceutical preparation that aims to treat or prevent glaucoma or ocular hypertension, particularly for patients who do not respond adequately to existing therapeutic agents. This preparation includes omidenepag, an ester, or a salt thereof, which has shown excellent efficacy in lowering intraocular pressure.

Career Highlights

Kawata has built a successful career at Santen Pharmaceutical Co., Ltd., where he has been instrumental in developing groundbreaking treatments for eye diseases. His expertise in pharmaceutical formulations has positioned him as a key figure in the industry.

Collaborations

Kawata has collaborated with notable colleagues, including Naveed Shams and Noriko Kawabata, to advance research and development in the field of ophthalmology.

Conclusion

Hisashi Kawata's innovative work in pharmaceutical formulations has significantly contributed to the treatment of glaucoma and ocular hypertension. His patents reflect a commitment to improving patient outcomes and advancing medical science.